Bezitramide: Difference between revisions

Page 1
Page 2
Content deleted Content added
CheMoBot (talk | contribs)
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoB
Fixed spacing between stub template and category templates.
 
(55 intermediate revisions by 39 users not shown)
Line 1: Line 1:
{{Short description|Opioid analgesic drug}}
{{Drugbox
{{Drugbox
| verifiedrevid = 444294220
| verifiedrevid = 447617484
| IUPAC_name = 4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1''H''-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile
| IUPAC_name = 4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1''H''-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile
| image = Bezitramide.svg
| image = Bezitramide.svg

<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename =
| pregnancy_category =
| pregnancy_category =
| legal_AU =
| legal_AU =
| legal_status =
| legal_BR = A1
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-04-04}}</ref>
| legal_CA = Schedule I
| legal_US = Schedule II
| legal_DE = Anlage I
| routes_of_administration = Oral
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| bioavailability =
| metabolism =
| metabolism =
| excretion =
| excretion =

<!--Identifiers-->
<!--Identifiers-->
| CASNo_Ref = {{cascite|??|??}}
| CAS_number = 15301-48-1
| CAS_number = 15301-48-1
| ATC_prefix = N02
| ATC_prefix = N02
Line 24: Line 25:
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01459
| DrugBank = DB01459
| KEGG = D07289
| ChEMBL = 2104149
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 55675
| ChemSpiderID = 55675
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3KXW0Y310I
| UNII = 3KXW0Y310I

<!--Chemical data-->
<!--Chemical data-->
| C=31 | H=32 | N=4 | O=2
| C=31 | H=32
| N=4 | O=2
| molecular_weight = 492.611 g/mol
| smiles = O=C(N2c1ccccc1N(C2=O)C5CCN(CCC(C#N)(c3ccccc3)c4ccccc4)CC5)CC
| smiles = O=C(N2c1ccccc1N(C2=O)C5CCN(CCC(C#N)(c3ccccc3)c4ccccc4)CC5)CC
| InChI = 1/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3
| InChIKey = FLKWNFFCSSJANB-UHFFFAOYAZ
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3
| StdInChI = 1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3
Line 40: Line 40:
| StdInChIKey = FLKWNFFCSSJANB-UHFFFAOYSA-N
| StdInChIKey = FLKWNFFCSSJANB-UHFFFAOYSA-N
}}
}}
'''Bezitramide''' is a narcotic [[analgesic]]. Bezitramide itself is a [[prodrug]] which is readily [[Hydrolysis|hydrolyzed]] in the [[gastrointestinal tract]] to its main [[metabolite]], despropionyl-bezitramide. Bezitramide was discovered at [[Janssen Pharmaceutica]] in 1961<ref>{{ cite patent
| country = US
| number = 3196157
| status = patent
| title = BENZIMIDAZOLINYL PIPERIDINES
| pubdate = 1963-06-11
| gdate = 1965-07-20
| inventor = Paul A. J. Janssen.
}}</ref>. It is most commonly marketed under the trade name Burgodin.


'''Bezitramide''' is an opioid [[analgesic]]. Bezitramide itself is a [[prodrug]] which is readily [[Hydrolysis|hydrolyzed]] in the [[gastrointestinal tract]] to its [[active metabolite]], despropionyl-bezitramide.<ref>{{cite journal | vauthors = Meijer DK, Hovinga G, Versluis A, Bröring J, van Aken K, Moolenaar F, Wesseling H | title = Pharmacokinetics of the oral narcotic analgesic bezitramide and preliminary observations on its effect on experimentally induced pain | journal = European Journal of Clinical Pharmacology | volume = 27 | issue = 5 | pages = 615–8 | year = 1984 | pmid = 6519169 | doi = 10.1007/BF00556902 | s2cid = 23978449 }}</ref> Bezitramide was discovered at [[Janssen Pharmaceutica]] in 1961.<ref>{{ cite patent | country = US | number = 3196157 | status = patent | title = Benzimidalinyl Piperidines | pubdate = 1963-06-11 | gdate = 1965-07-20 | inventor = Janssen PA }}</ref><ref>{{cite journal | vauthors = Janssen PA, Niemegeers CJ, Schellekens KH, Marsboom RH, Herin VV, Amery WK, Admiraal PV, Bosker JT, Crul JF, Pearce C, Zegveld C | display-authors = 6 | title = Bezitramide (R 4845), a new potent and orally long-acting analgesic compound | journal = Arzneimittel-Forschung | volume = 21 | issue = 6 | pages = 862–7 | date = June 1971 | pmid = 5109278 }}</ref><ref>{{cite journal | vauthors = Knape H | title = Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report) | journal = British Journal of Anaesthesia | volume = 42 | issue = 4 | pages = 325–8 | date = April 1970 | pmid = 4913411 | doi = 10.1093/bja/42.4.325 | doi-access = free }}</ref> It is most commonly marketed under the trade name '''Burgodin'''.
The drug was pulled from the shelves in the Netherlands in 2004 after fatal overdose cases, including one where a five year old child took one tablet from his mother's purse, ate it, and promptly died.{{Fact|date=March 2007}}


The drug was pulled from the shelves in the [[Netherlands]] in 2004 after fatal overdose cases, including one where a five-year-old child took one tablet from his mother's purse, ate it, and promptly died.<ref>{{cite journal | vauthors = de Vos JC, Rohof OJ, Bernsen PJ, Conemans JM, van Unnik AJ | title = [Death caused by one tablet of Burgodin] | journal = Nederlands Tijdschrift voor Geneeskunde | volume = 127 | issue = 34 | pages = 1552–3 | date = August 1983 | pmid = 6633692 }}</ref>
Bezitramide is regulated much the same as [[morphine]] in all known jurisdictions and is, surprisingly, a [[Controlled Substances Act |Schedule II]] rather than Schedule I [[narcotic]] under the United States' Controlled Substances Act of 1970. However, it has to this point never been marketed in the United States.


Bezitramide is regulated much the same as [[morphine]] in all known jurisdictions and is a [[Controlled Substances Act|Schedule II]] substance under the United States' Controlled Substances Act of 1970, with an ACSCN of 9800 and zero annual manufacturing quota.<ref>{{Cite web |url=http://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm |title=Title 21 United States Code (USC) Controlled Substances Act |access-date=2011-09-29 |archive-date=2020-08-30 |archive-url=https://web.archive.org/web/20200830032541/https://www.deadiversion.usdoj.gov/21cfr/21usc/812.htm |url-status=dead }}</ref> However, as of May 2021, it has never been marketed in the United States.
Other drugs which are legal for medical use in the US but not marketed up to this point in time include [[phenazocine]], [[metopon]], [[alphaprodine]] (formerly marketed as Nisentil) , [[anileridine]] (formerly marketed as Leritine), [[ethylmorphine]] (regulated like codeine and therefore preparations with other active ingredients can be Schedule III or Schedule V), [[isomethadone]], [[levomethorphan]], [[metazocine]], [[piminodine]] (formerly marketed as Alvodine), [[racemethorphan]], [[moramide intermediate]] (the most common moramide, the Schedule I [[dextromoramide]] was once marketed in the US as Dimorlin for a short time in the 1950s), and [[racemorphan]]. <!--The previous paragraph has almost nothing to do with Bezitramide. It doesn't belong on this page-->
==See also==
* [[Benperidol]]
* [[Brorphine]]
* [[J-113,397]]


==References==
== References ==
{{Reflist}}
{{Reflist|2}}

* Knape H., Bezitramide, an orally active analgesic. An investigation on pain following operations for lumbar disc protrusion (preliminary report), Br J Anaesth. 1970 Apr;42(4):325-8.
{{Analgesics}}
* Janssen PA, Niemegeers CJ, Schellekens KH, Marsboom RH, Herin VV, Amery WK, Admiraal PV, Bosker JT, Crul JF, Pearce C, Zegveld C., Bezitramide (R 4845), a new potent and orally long-acting analgesic compound, Arzneimittelforschung. 1971 Jun;21(6):862-7.
{{Opioidergics}}
* de Vos JC, Rohof OJ, Bernsen PJ, Conemans JM, van Unnik AJ. Death caused by one tablet of Burgodin. (Dutch). Nederlands Tijdschrift voor Geneeskunde. 1983 Aug 20;127(34):1552-3. PMID: 6633692


[[Category:Synthetic opioids]]
[[Category:Synthetic opioids]]
Line 69: Line 64:
[[Category:Ureas]]
[[Category:Ureas]]
[[Category:Propionamides]]
[[Category:Propionamides]]
[[Category:Mu-opioid agonists]]
[[Category:Mu-opioid receptor agonists]]
[[Category:Janssen Pharmaceutica]]
[[Category:Janssen Pharmaceutica]]
[[Category:Belgian inventions]]


{{analgesic-stub}}


{{analgesic-stub}}
[[ru:Безитрамид]]
[[sv:Besitramid]]